THERAGENICS CORP (CIK: 0000795551) EDGAR, Information, Filings... CompaniesBIO.Com

THERAGENICS CORP

Mailing address
5203 BRISTOL INDUSTRIAL WAY, BUFORD, Delaware, 30518
Phone
7702710233
State location
Georgia
State of incorporation
Delaware
Fiscal year end
December 31
SIC
3825 - (CF Office: Office of Life Sciences) INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS
Filings
N/A

THERAGENICS CORP (CIK: 0000795551) is an American company incorporated in the state of Georgia. Head office is located at 5203 BRISTOL INDUSTRIAL WAY, BUFORD, Georgia, 30518. Work in the industry 3825 - (CF Office: Office of Life Sciences) INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS. THERAGENICS CORP is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Plante Joseph	0001477942	Oct-05-2009	officer: President, NeedleTech Products
Zeman Janet	0001445151	Sep-12-2008	officer: General Manager, CP Medical
Small C. Russell	0001442080	Jul-28-2008	officer: VP, NeedleTech Products
Routhier Ronald	0001442081	Jul-28-2008	officer: President, NeedleTech Products
DAHLBERG KATHLEEN	0001192107	May-15-2008	director
Engwall K Wyatt	0001435238	May-15-2008	director
MOODY CHARLES D JR	0001274106	Nov-14-2007	director
Lang Michael Francis	0001413342	Sep-17-2007	officer: President, Galt Medical
Starkey Judith	0001400173	May-17-2007	director
Griffith Luther T	0001308195	Aug-07-2006	director
Eddings James	0001371627	Aug-02-2006	officer: President, Galt Medical
Tarallo Francis J	0001332909	Aug-16-2005	officer: CFO & Treasurer
Ferguson Patrick	0001326609	May-06-2005	officer: President
SMITH BRUCE W	0001213035	Aug-10-2004	officer: Exec. VP
JACOBS M CHRISTINE	0001197904	Aug-04-2004	officer: Chief Executive Officer
CULVER TRACY M	0001283207	Mar-01-2004	officer: Secretary and General Counsel
OBANNON MICHAEL	0001283224	Mar-01-2004	officer: Vice President
INCARNATI PHILIP A	0001213034	Nov-21-2003	director
SAUNDERS PETER A A	0001060868	Nov-11-2003	director
CARTER ORWIN L	0001213031	Nov-11-2003	director
FLINN PATRICK L	0001213032	Nov-11-2003	director
HERNDON JOHN V	0001213033	Nov-11-2003	director
MACLENNAN JAMES A	0001213036	Jul-29-2003	officer: CFO and Treasurer
DEAVENPORT EARNEST W JR	0001183377	Mar-12-2003	director
BRAWLEY OTIS W	0001213029	Mar-12-2003	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by THERAGENICS CORP

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001037389-14-000031 (34 Act) Size: KB	Feb-13-2014	005-53277 14606171
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001167674-14-000866 (34 Act) Size: KB	Feb-10-2014	005-53277 14589144
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001188112-13-003321 (34 Act) Size: KB	Nov-12-2013	000-15443 131208889
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001188112-13-003226 (33 Act) Size: KB	Nov-06-2013	333-165503 131197599
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001188112-13-003225 (33 Act) Size: KB	Nov-06-2013	333-181573 131197595
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001188112-13-003224 (33 Act) Size: KB	Nov-06-2013	333-15313 131197594
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001188112-13-003223 (33 Act) Size: KB	Nov-06-2013	333-48136 131197579
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001188112-13-003222 (33 Act) Size: KB	Nov-06-2013	333-136640 131197569
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001188112-13-003221 (33 Act) Size: KB	Nov-06-2013	333-40653 131197559
EFFECT	Document	Acc-no: 9999999995-13-003164 (33 Act) Size: KB	Nov-05-2013	333-143839 131194523
EFFECT	Document	Acc-no: 9999999995-13-003163 (33 Act) Size: KB	Nov-05-2013	333-127551 131194522
8-K	Document	Current report filing Acc-no: 0001188112-13-003155 (34 Act) Size: KB	Nov-04-2013	001-14339 131190175
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000795551-13-000023 ( Act) Size: 0 KB	Oct-31-2013
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000795551-13-000022 ( Act) Size: 0 KB	Oct-31-2013
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000795551-13-000021 ( Act) Size: 0 KB	Oct-31-2013
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000795551-13-000020 ( Act) Size: 0 KB	Oct-31-2013
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000795551-13-000019 ( Act) Size: 0 KB	Oct-31-2013
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000795551-13-000018 ( Act) Size: 0 KB	Oct-31-2013
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000795551-13-000017 ( Act) Size: 0 KB	Oct-31-2013
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000795551-13-000016 ( Act) Size: 0 KB	Oct-31-2013

Recent 20 filings. View all THERAGENICS CORP filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

THERAGENICS CORP overview
THERAGENICS CORP job
THERAGENICS CORP stock
THERAGENICS CORP ownership
THERAGENICS CORP CEO
THERAGENICS CORP documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.